Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Gilead Sciences - 33 Year Stock Price History | GILD

Historical daily share price chart and data for Gilead Sciences since 1992 adjusted for splits and dividends. The latest closing stock price for Gilead Sciences as of June 06, 2025 is 112.46.
  • The all-time high Gilead Sciences stock closing price was 116.59 on March 07, 2025.
  • The Gilead Sciences 52-week high stock price is 119.96, which is 6.7% above the current share price.
  • The Gilead Sciences 52-week low stock price is 62.69, which is 44.3% below the current share price.
  • The average Gilead Sciences stock price for the last 52 weeks is 91.30.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Gilead Sciences Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 103.8987 91.2396 116.5920 88.5187 112.4600 22.60%
2024 75.3991 79.4146 96.4074 61.1348 91.7262 18.68%
2023 74.0325 78.4360 80.9069 69.2271 77.2870 -1.99%
2022 60.2020 63.7598 81.5077 50.8813 78.8585 23.63%
2021 58.0776 50.6419 64.6910 50.5492 63.7862 29.95%
2020 56.5984 52.8106 68.6403 47.7269 49.0833 -6.70%
2019 52.0453 49.4591 55.1335 48.7017 52.6082 7.88%
2018 56.4857 55.9943 67.1025 47.1982 48.7652 -9.92%
2017 53.8100 54.4528 63.7490 47.4431 54.1354 2.96%
2016 60.5060 70.3372 73.7626 52.3535 52.5804 -27.59%
2015 75.8123 67.3099 86.9849 67.3099 72.6194 8.63%
2014 63.5290 53.3387 81.0044 46.4382 66.8489 25.51%
2013 39.7579 26.6162 53.3316 26.5771 53.2607 104.49%
2012 20.0423 14.8435 27.0700 14.8435 26.0452 79.45%
2011 14.1584 12.9712 15.3222 12.5315 14.5137 12.94%
2010 13.9253 15.3541 17.5349 11.2869 12.8506 -16.25%
2009 16.3523 18.5029 18.7228 14.6946 15.3435 -15.39%
2008 17.4410 16.0775 20.2476 13.2868 18.1342 11.15%
2007 14.0349 11.1964 16.9285 11.1220 16.3151 41.72%
2006 10.9765 9.6983 12.3666 9.5298 11.5120 23.51%
2005 7.4954 6.1576 9.8632 5.5034 9.3206 50.24%
2004 5.7044 5.1434 6.9218 4.5885 6.2037 20.08%
2003 4.5647 3.0929 6.2045 2.8634 5.1665 71.41%
2002 3.0193 2.7229 3.5202 2.3536 3.0141 3.47%
2001 2.2226 1.6428 3.2007 1.1982 2.9130 58.48%
2000 1.6698 1.2480 2.5747 0.9627 1.8381 53.24%
1999 1.1830 0.8810 2.0472 0.7923 1.1995 31.81%
1998 0.7068 0.8449 0.9586 0.4045 0.9100 7.35%
1997 0.6948 0.5430 1.0222 0.4793 0.8477 52.99%
1996 0.6297 0.7230 0.9281 0.3823 0.5541 -21.87%
1995 0.4085 0.2078 0.7147 0.2078 0.7092 236.75%
1994 0.2229 0.2659 0.3103 0.1552 0.2106 -20.80%
1993 0.3278 0.4045 0.4239 0.2382 0.2659 -37.68%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $137.404B $28.754B
Gilead Sciences is a pioneer in developing drugs for the treatment of human immunodeficiency virus, liver diseases, hematology/oncology diseases and inflammation/respiratory diseases. The company has a strong HIV franchise with key HIV/AIDS therapies like tenofovir alafenamide based products - Genvoya, Odefsey, Descovy, Biktarvy and Truvada. The portfolio also includes hepatitis C virus drugs like Harvoni and Epclusa and HBV drug. The first cell therapy approved for the treatment of adult patients with relapsed or refractory large B-cell lymphoma, has diversified Gilead's portfolio. Tecartus, another CAR T-cell therapy, was granted an accelerated approval in the United States for the treatment of relapsed or refractory mantle cell lymphoma. The company is also working on diversifying and growing its business beyond antivirals into other therapeutic areas. Gilead is also making inroads in the oncology space with strategic collaborations and acquisitions.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $224.377B 16.75
Amgen (AMGN) United States $154.375B 13.83
Vertex Pharmaceuticals (VRTX) United States $113.972B 0.00
Bristol Myers Squibb (BMY) United States $97.358B 6.52
GSK (GSK) United Kingdom $84.341B 10.09
CSL (CSLLY) Australia $76.578B 0.00
Regeneron Pharmaceuticals (REGN) United States $52.155B 12.66
Alnylam Pharmaceuticals (ALNY) United States $40.160B 0.00
Argenex SE (ARGX) Netherlands $35.451B 96.76
BeOne Medicines - (ONC) Cayman Islands $30.424B 0.00
BioNTech SE (BNTX) Germany $26.479B 0.00
Biogen (BIIB) United States $19.101B 8.24
Royalty Pharma (RPRX) United States $18.976B 8.02
Genmab (GNMSF) Denmark $14.413B 14.74
Genmab (GMAB) Denmark $13.985B 15.69
Insmed (INSM) United States $13.249B 0.00
Illumina (ILMN) United States $13.020B 24.70
Incyte (INCY) United States $13.016B 98.88
Exelixis (EXEL) United States $11.555B 19.62
Ascendis Pharma (ASND) Denmark $10.825B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $10.783B 27.54
BioMarin Pharmaceutical (BMRN) United States $10.599B 17.22
Exact Sciences (EXAS) United States $10.258B 0.00
QIAGEN (QGEN) Netherlands $10.128B 19.71
Moderna (MRNA) United States $10.102B 0.00
Blueprint Medicines (BPMC) United States $8.260B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $8.132B 0.00
Roivant Sciences (ROIV) United Kingdom $7.614B 0.00
Bio-Techne Corp (TECH) United States $7.573B 28.25
Revolution Medicines (RVMD) United States $7.488B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $7.282B 0.00
Repligen (RGEN) United States $7.118B 79.69
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Jazz Pharmaceuticals (JAZZ) Ireland $6.708B 6.46
Halozyme Therapeutics (HALO) United States $6.598B 12.63
TG Therapeutics (TGTX) United States $6.239B 163.75
Guardant Health (GH) United States $5.997B 0.00
Telix Pharmaceuticals (TLX) Australia $5.870B 0.00
Legend Biotech (LEGN) United States $5.785B 0.00
Nuvalent (NUVL) United States $5.608B 0.00
Axsome Therapeutics (AXSM) United States $5.449B 0.00
Alkermes (ALKS) Ireland $5.112B 13.72
Zealand Pharma (ZLDPF) Denmark $5.051B 0.00
ADMA Biologics Inc (ADMA) United States $4.760B 35.61
Vaxcyte (PCVX) United States $4.489B 0.00
Akero Therapeutics (AKRO) United States $4.300B 0.00
Avidity Biosciences (RNA) United States $4.289B 0.00
Rhythm Pharmaceuticals (RYTM) United States $4.210B 0.00
PTC Therapeutics (PTCT) United States $4.100B 7.14
Zai Lab (ZLAB) China $4.031B 0.00
Merus (MRUS) Netherlands $3.877B 0.00
Sarepta Therapeutics (SRPT) United States $3.853B 0.00
Krystal Biotech (KRYS) United States $3.833B 29.54
Cytokinetics (CYTK) United States $3.831B 0.00
Arcellx (ACLX) United States $3.651B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.572B 31.38
SpringWorks Therapeutics (SWTX) United States $3.526B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.490B 0.00
Protagonist Therapeutics (PTGX) United States $3.336B 71.76
CRISPR Therapeutics AG (CRSP) Switzerland $3.331B 0.00
Scholar Rock Holding (SRRK) United States $3.252B 0.00
Alvotech (ALVO) Luxembourg $3.166B 18.10
MoonLake Immunotherapeutics (MLTX) Switzerland $3.126B 0.00
Kymera Therapeutics (KYMR) United States $3.104B 0.00
Viking Therapeutics (VKTX) United States $3.037B 0.00
Metsera (MTSR) United States $3.012B 0.00
Immunovant (IMVT) United States $2.738B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.660B 0.00
ImmunityBio (IBRX) United States $2.560B 0.00
Ascentage Pharma Group - (AAPG) China $2.437B 0.00
Apellis Pharmaceuticals (APLS) United States $2.401B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.358B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.273B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.212B 0.00
Vericel (VCEL) United States $2.185B 1446.67
Bavarian Nordic (BVNRY) Denmark $2.160B 11.41
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.154B 0.00
Denali Therapeutics (DNLI) United States $2.066B 0.00
Belite Bio (BLTE) United States $2.045B 0.00
CG Oncology (CGON) United States $2.030B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.012B 13.37
Ligand Pharmaceuticals (LGND) United States $2.010B 0.00
Vera Therapeutics (VERA) United States $1.953B 0.00
Agios Pharmaceuticals (AGIO) United States $1.945B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.910B 0.00
Certara (CERT) United States $1.898B 35.46
Tarsus Pharmaceuticals (TARS) United States $1.852B 0.00
IDEAYA Biosciences (IDYA) United States $1.848B 0.00
Amicus Therapeutics (FOLD) United States $1.835B 198.67
NovoCure (NVCR) Jersey $1.834B 0.00
Twist Bioscience (TWST) United States $1.817B 0.00
Apogee Therapeutics (APGE) United States $1.734B 0.00
Beam Therapeutics (BEAM) United States $1.709B 0.00
Disc Medicine (IRON) United States $1.663B 0.00
Biohaven (BHVN) United States $1.654B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.610B 0.00
Edgewise Therapeutics (EWTX) United States $1.559B 0.00
Liquidia Technologies (LQDA) United States $1.540B 0.00
Adaptive Biotechnologies (ADPT) United States $1.499B 0.00
Mesoblast (MESO) Australia $1.484B 0.00
Janux Therapeutics (JANX) United States $1.465B 0.00
89BIO (ETNB) United States $1.454B 0.00
GRAIL (GRAL) United States $1.421B 0.00
Travere Therapeutics (TVTX) United States $1.307B 0.00
MannKind (MNKD) United States $1.307B 26.88
ANI Pharmaceuticals (ANIP) United States $1.297B 13.37
Celldex Therapeutics (CLDX) United States $1.296B 0.00
BGM Group (BGM) China $1.250B 0.00
Pacira BioSciences (PCRX) United States $1.238B 11.78
Structure Therapeutics (GPCR) United States $1.231B 0.00
Anbio Biotechnology (NNNN) Germany $1.203B 0.00
Dynavax Technologies (DVAX) United States $1.195B 71.07
Viridian Therapeutics (VRDN) United States $1.162B 0.00
Novavax (NVAX) United States $1.132B 2.64
WAVE Life Sciences (WVE) Singapore $1.040B 0.00
Arcus Biosciences (RCUS) United States $1.020B 0.00
Mineralys Therapeutics (MLYS) United States $1.018B 0.00
Spyre Therapeutics (SYRE) United States $1.002B 0.00
CureVac (CVAC) Germany $1.001B 4.85
Geron (GERN) United States $0.994B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.960B 0.00
Nurix Therapeutics (NRIX) United States $0.953B 0.00
MiMedx (MDXG) United States $0.936B 22.64
NeoGenomics (NEO) United States $0.918B 0.00
UniQure (QURE) Netherlands $0.910B 0.00
Niagen Bioscience (NAGE) United States $0.907B 127.89
CorMedix Inc (CRMD) United States $0.894B 59.91
Praxis Precision Medicines (PRAX) United States $0.861B 0.00
Oculis Holding AG (OCS) Switzerland $0.854B 0.00
LENZ Therapeutics (LENZ) United States $0.853B 0.00
Zymeworks (ZYME) United States $0.844B 0.00
Nuvation Bio (NUVB) United States $0.844B 0.00
Pharvaris (PHVS) Netherlands $0.839B 0.00
ArriVent BioPharma (AVBP) United States $0.803B 0.00
Immunome (IMNM) United States $0.794B 0.00
Intellia Therapeutics (NTLA) United States $0.785B 0.00
Pharming Group (PHAR) Netherlands $0.763B 0.00
Replimune (REPL) United States $0.752B 0.00
Gyre Therapeutics (GYRE) United States $0.747B 199.25
Vir Biotechnology (VIR) United States $0.712B 0.00
Sionna Therapeutics (SION) United States $0.707B 0.00
AbCellera Biologics (ABCL) Canada $0.707B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.704B 0.00
Immatics (IMTX) Germany $0.703B 0.00
Cogent Biosciences (COGT) United States $0.682B 0.00
Trevi Therapeutics (TRVI) United States $0.673B 0.00
Pharming Group (PHGUF) Netherlands $0.671B 0.00
Anavex Life Sciences (AVXL) United States $0.664B 0.00
GH Research (GHRS) Ireland $0.656B 0.00
Arbutus Biopharma (ABUS) United States $0.651B 0.00
Oric Pharmaceuticals (ORIC) United States $0.651B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.626B 0.00
AnaptysBio (ANAB) United States $0.621B 0.00
Keros Therapeutics (KROS) United States $0.614B 0.00
Bicara Therapeutics (BCAX) United States $0.602B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.601B 0.00
Iovance Biotherapeutics (IOVA) United States $0.601B 0.00
Dianthus Therapeutics (DNTH) United States $0.597B 0.00
Stoke Therapeutics (STOK) United States $0.594B 13.77
Bicycle Therapeutics (BCYC) United Kingdom $0.589B 0.00
Maze Therapeutics (MAZE) United States $0.584B 0.00
Upstream Bio (UPB) United States $0.583B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.581B 0.00
Sana Biotechnology (SANA) United States $0.575B 0.00
Kura Oncology (KURA) United States $0.569B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.568B 0.00
Tyra Biosciences (TYRA) United States $0.540B 0.00
Opthea (OPT) Australia $0.525B 0.00
Abivax SA (ABVX) France $0.517B 0.00
Cullinan Therapeutics (CGEM) United States $0.516B 0.00
Arvinas (ARVN) United States $0.505B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.494B 0.00
Castle Biosciences (CSTL) United States $0.491B 33.37
ATyr Pharma (ATYR) United States $0.476B 0.00
Septerna (SEPN) United States $0.469B 0.00
Fortrea Holdings (FTRE) United States $0.463B 12.80
Eton Pharmaceuticals (ETON) United States $0.463B 0.00
Myriad Genetics (MYGN) United States $0.454B 0.00
PureTech Health (PRTC) United States $0.452B 0.00
Rapport Therapeutics (RAPP) United States $0.450B 0.00
Celcuity (CELC) United States $0.446B 0.00
Erasca (ERAS) United States $0.445B 0.00
MeiraGTx Holdings (MGTX) United States $0.440B 0.00
Sage Therapeutics (SAGE) United States $0.425B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.423B 0.00
Cytek Biosciences (CTKB) United States $0.423B 0.00
REGENXBIO (RGNX) United States $0.419B 0.00
Tectonic Therapeutic (TECX) United States $0.419B 0.00
Humacyte (HUMA) United States $0.406B 0.00
Zenas BioPharma (ZBIO) United States $0.402B 0.00
Benitec Biopharma (BNTC) United States $0.398B 0.00
MBX Biosciences (MBX) United States $0.396B 0.00
Precigen (PGEN) United States $0.393B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.391B 0.00
Kamada (KMDA) Israel $0.390B 23.38
ITeos Therapeutics (ITOS) United States $0.390B 0.00
Fulcrum Therapeutics (FULC) United States $0.384B 0.00
Tango Therapeutics (TNGX) United States $0.380B 0.00
Checkpoint Therapeutics (CKPT) United States $0.371B 0.00
Rezolute (RZLT) United States $0.369B 0.00
Vigil Neuroscience (VIGL) United States $0.368B 0.00
Northwest Biotherapeutics (NWBO) United States $0.364B 0.00
Absci (ABSI) United States $0.362B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.341B 0.00
Verastem (VSTM) United States $0.340B 0.00
Abeona Therapeutics (ABEO) United States $0.332B 0.00
Solid Biosciences (SLDB) United States $0.329B 0.00
Emergent Biosolutions (EBS) United States $0.328B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.327B 0.00
Neurogene (NGNE) United States $0.327B 0.00
Compass Therapeutics (CMPX) United States $0.326B 0.00
Inventiva S.A (IVA) France $0.326B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.323B 0.00
Terns Pharmaceuticals (TERN) United States $0.309B 0.00
Alpha Teknova (TKNO) United States $0.308B 0.00
Entrada Therapeutics (TRDA) United States $0.308B 10.02
Aura Biosciences (AURA) United States $0.307B 0.00
Cidara Therapeutics (CDTX) United States $0.302B 0.00
XOMA Royalty (XOMA) United States $0.299B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.297B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.296B 0.00
Astria Therapeutics (ATXS) United States $0.295B 0.00
Olema Pharmaceuticals (OLMA) United States $0.288B 0.00
Gossamer Bio (GOSS) United States $0.286B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.284B 57.75
Allogene Therapeutics (ALLO) United States $0.282B 0.00
Annexon (ANNX) United States $0.280B 0.00
Ocugen (OCGN) United States $0.278B 0.00
Candel Therapeutics (CADL) United States $0.278B 0.00
Atea Pharmaceuticals (AVIR) United States $0.273B 0.00
Prothena (PRTA) Ireland $0.272B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.267B 0.00
2seventy Bio (TSVT) United States $0.266B 0.00
Prima BioMed (IMMP) Australia $0.260B 0.00
Palvella Therapeutics (PVLA) United States $0.260B 0.00
Semper Paratus Acquisition (TVGN) United States $0.259B 0.00
Aardvark Therapeutics (AARD) United States $0.259B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.259B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.259B 0.00
Inozyme Pharma (INZY) United States $0.258B 0.00
Lifecore Biomedical (LFCR) United States $0.250B 0.00
Amarin (AMRN) Ireland $0.245B 0.00
Cartesian Therapeutics (RNAC) United States $0.242B 0.00
Cardiff Oncology (CRDF) United States $0.241B 0.00
Third Harmonic Bio (THRD) United States $0.239B 0.00
Urogen Pharma (URGN) United States $0.237B 0.00
DBV Technologies S.A (DBVT) France $0.234B 0.00
Monopar Therapeutics (MNPR) United States $0.232B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.231B 0.00
Foghorn Therapeutics (FHTX) United States $0.230B 0.00
Tvardi Therapeutics (TVRD) United States $0.229B 0.00
ACELYRIN, INC (SLRN) United States $0.229B 0.00
MaxCyte (MXCT) United States $0.229B 0.00
BioStem Technologies (BSEM) $0.228B 9.29
Design Therapeutics (DSGN) United States $0.227B 0.00
GENFIT S.A (GNFT) France $0.223B 0.00
Adherex Technologies (FENC) United States $0.218B 0.00
ScPharmaceuticals (SCPH) United States $0.217B 0.00
Adocia (ADOCY) France $0.213B 0.00
CARGO Therapeutics (CRGX) United States $0.210B 0.00
Kodiak Sciences (KOD) United States $0.207B 0.00
Instil Bio (TIL) United States $0.199B 0.00
Innate Pharma S.A (IPHA) France $0.198B 0.00
Bright Minds Biosciences (DRUG) United States $0.196B 0.00
CytomX Therapeutics (CTMX) United States $0.193B 5.00
ProQR Therapeutics (PRQR) Netherlands $0.188B 0.00
Nuvectis Pharma (NVCT) United States $0.187B 0.00
Codexis (CDXS) United States $0.187B 0.00
I-Mab (IMAB) United States $0.187B 0.00
Inhibrx Biosciences (INBX) United States $0.187B 0.11
EnGene Holdings (ENGN) Canada $0.185B 0.00
Voyager Therapeutics (VYGR) United States $0.183B 0.00
Puma Biotechnology (PBYI) United States $0.181B 4.74
Prime Medicine (PRME) United States $0.179B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.178B 0.00
Actuate Therapeutics (ACTU) United States $0.178B 0.00
DiaMedica Therapeutics (DMAC) United States $0.175B 0.00
AC Immune (ACIU) Switzerland $0.174B 0.00
INmune Bio (INMB) United States $0.169B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.165B 0.00
Galena Biopharma (SLS) United States $0.163B 0.00
Anika Therapeutics (ANIK) United States $0.160B 0.00
Ventyx Biosciences (VTYX) United States $0.160B 0.00
BioAge Labs (BIOA) United States $0.159B 0.00
Alumis (ALMS) United States $0.158B 0.00
Alpha Cognition (ACOG) Canada $0.155B 0.00
Fate Therapeutics (FATE) United States $0.154B 0.00
Compugen (CGEN) Israel $0.153B 0.00
Editas Medicine (EDIT) United States $0.151B 0.00
Sagimet Biosciences (SGMT) United States $0.147B 0.00
Molecular Partners AG (MOLN) Switzerland $0.144B 0.00
Spero Therapeutics (SPRO) United States $0.143B 0.00
Black Diamond Therapeutics (BDTX) United States $0.142B 41.50
Agenus (AGEN) United States $0.141B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.141B 0.00
Alector (ALEC) United States $0.141B 0.00
Rapt Therapeutics (RAPT) United States $0.135B 0.00
23andMe Holding (MEHCQ) United States $0.132B 0.00
Neumora Therapeutics (NMRA) United States $0.131B 0.00
Nkarta (NKTX) United States $0.130B 0.00
Seer (SEER) United States $0.128B 0.00
Kyverna Therapeutics (KYTX) United States $0.127B 0.00
TuHURA Biosciences (HURA) United States $0.126B 0.00
Greenwich LifeSciences (GLSI) United States $0.126B 0.00
Theratechnologies (THTX) Canada $0.121B 0.00
Elicio Therapeutics (ELTX) United States $0.120B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.117B 0.00
Sangamo Therapeutics (SGMO) United States $0.115B 0.00
EXoZymes (EXOZ) United States $0.114B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.114B 0.00
BioHarvest Sciences (BHST) Canada $0.113B 0.00
Invivyd (IVVD) United States $0.111B 0.00
Cabaletta Bio (CABA) United States $0.111B 0.00
Contineum Therapeutics (CTNM) United States $0.107B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.106B 0.00
C4 Therapeutics (CCCC) United States $0.104B 0.00
Caribou Biosciences (CRBU) United States $0.101B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.100B 0.00
Pliant Therapeutics (PLRX) United States $0.099B 0.00
IO Biotech (IOBT) Denmark $0.099B 0.00
HilleVax (HLVX) United States $0.098B 0.00
Coya Therapeutics (COYA) United States $0.097B 0.00
Genelux (GNLX) United States $0.095B 0.00
TScan Therapeutics (TCRX) United States $0.095B 0.00
Nautilus Biotechnology (NAUT) United States $0.094B 0.00
Coherus BioSciences (CHRS) United States $0.093B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.093B 0.00
Senti Biosciences (SNTI) United States $0.093B 0.00
Biomea Fusion (BMEA) United States $0.092B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.091B 0.00
Entera Bio (ENTX) Israel $0.091B 0.00
Tenaya Therapeutics (TNYA) United States $0.088B 0.00
XBiotech (XBIT) United States $0.087B 0.00
Jasper Therapeutics (JSPR) United States $0.086B 0.00
Climb Bio (CLYM) United States $0.084B 0.00
Adagene (ADAG) China $0.083B 0.00
Cellectis S.A (CLLS) France $0.080B 0.00
Whitehawk Therapeutics (WHWK) United States $0.079B 0.00
Genenta Science S.p.A (GNTA) Italy $0.079B 0.00
Zura Bio (ZURA) United States $0.079B 0.00
Inovio Pharmaceuticals (INO) United States $0.078B 0.00
TELA Bio (TELA) United States $0.077B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.076B 0.00
Elutia (ELUT) United States $0.075B 0.00
IGM Biosciences (IGMS) United States $0.074B 0.00
Immunic (IMUX) United States $0.074B 0.00
Immuneering (IMRX) United States $0.074B 0.00
PDS Biotechnology (PDSB) United States $0.071B 0.00
Sutro Biopharma (STRO) United States $0.070B 0.00
Citius Oncology (CTOR) United States $0.069B 0.00
VistaGen Therapeutics (VTGN) United States $0.068B 0.00
MediciNova (MNOV) United States $0.068B 0.00
Forte Biosciences (FBRX) United States $0.068B 0.00
BeyondSpring (BYSI) United States $0.068B 0.00
ZIVO Bioscience (ZIVO) United States $0.067B 0.00
Skye Bioscience (SKYE) United States $0.067B 0.00
CervoMed (CRVO) United States $0.066B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.065B 0.00
Alto Neuroscience (ANRO) United States $0.064B 0.00
Adlai Nortye (ANL) Cayman Islands $0.064B 0.00
Repare Therapeutics (RPTX) Canada $0.064B 0.00
Seres Therapeutics (MCRB) United States $0.063B 0.00
OKYO Pharma (OKYO) $0.063B 0.00
Oncobiologics (OTLK) United States $0.063B 0.00
Ikena Oncology (IKNA) United States $0.063B 0.00
Exicure (XCUR) United States $0.063B 0.00
Adicet Bio (ACET) United States $0.062B 0.00
Immix Biopharma (IMMX) United States $0.061B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.061B 0.00
Clearside Biomedical (CLSD) United States $0.060B 0.00
Opus Genetics (IRD) United States $0.060B 0.00
Annovis Bio (ANVS) United States $0.059B 0.00
Kalaris Therapeutics (KLRS) United States $0.058B 0.00
InflaRx (IFRX) Germany $0.057B 0.00
Precision BioSciences (DTIL) United States $0.057B 0.00
Akoya Biosciences (AKYA) United States $0.057B 0.00
Fortress Biotech (FBIO) United States $0.056B 0.00
Werewolf Therapeutics (HOWL) United States $0.055B 0.00
Quince Therapeutics (QNCX) United States $0.054B 0.00
Renovaro (RENB) United States $0.054B 0.00
VTv Therapeutics (VTVT) United States $0.053B 0.00
Kronos Bio (KRON) United States $0.053B 0.00
Applied Therapeutics (APLT) United States $0.052B 0.00
RenovoRx (RNXT) United States $0.051B 0.00
Shattuck Labs (STTK) United States $0.051B 0.00
Adverum Biotechnologies (ADVM) United States $0.051B 0.00
Atara Biotherapeutics (ATRA) United States $0.050B 0.00
Bluebird Bio (BLUE) United States $0.049B 0.00
Artiva Biotherapeutics (ARTV) United States $0.048B 0.00
Cue Biopharma (CUE) United States $0.047B 0.00
PepGen (PEPG) United States $0.046B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.046B 0.00
Celularity (CELU) United States $0.046B 0.00
Mersana Therapeutics (MRSN) United States $0.046B 0.00
Scilex Holding (SCLX) United States $0.045B 0.00
Connect Biopharma Holdings (CNTB) United States $0.043B 0.00
Rein Therapeutics (RNTX) United States $0.043B 0.00
Alterity Therapeutics - (ATHE) Australia $0.043B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.042B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.041B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.040B 0.00
Clene (CLNN) United States $0.039B 0.00
OnKure Therapeutics (OKUR) United States $0.039B 0.00
Estrella Immunopharma (ESLA) United States $0.038B 0.00
CAMP4 Therapeutics (CAMP) United States $0.038B 0.00
Pluri (PLUR) Israel $0.037B 0.00
Quantum Biopharma (QNTM) Canada $0.037B 0.00
Aligos Therapeutics (ALGS) United States $0.037B 0.00
Lantern Pharma (LTRN) United States $0.037B 0.00
Medicus Pharma (MDCX) United States $0.037B 0.00
Radiopharm Theranostics - (RADX) Australia $0.036B 0.00
Xilio Therapeutics (XLO) United States $0.035B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.034B 0.00
AN2 Therapeutics (ANTX) United States $0.033B 0.00
FibroBiologics (FBLG) United States $0.033B 0.00
Kezar Life Sciences (KZR) United States $0.032B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.031B 0.00
Rani Therapeutics Holdings (RANI) United States $0.030B 0.00
Grace Therapeutics (GRCE) Canada $0.030B 0.00
Allakos (ALLK) United States $0.030B 0.00
Dyadic (DYAI) United States $0.029B 0.00
MiNK Therapeutics (INKT) United States $0.029B 0.00
Dare Bioscience (DARE) United States $0.029B 0.00
Oncolytics Biotech (ONCY) Canada $0.029B 0.00
Cadrenal Therapeutics (CVKD) United States $0.029B 0.00
ALX Oncology Holdings (ALXO) United States $0.028B 0.00
Passage Bio (PASG) United States $0.028B 0.00
Vor Biopharma (VOR) $0.028B 0.00
KALA BIO (KALA) United States $0.027B 0.00
BioAtla (BCAB) United States $0.027B 0.00
Boundless Bio (BOLD) United States $0.026B 0.00
ABVC BioPharma (ABVC) United States $0.025B 0.00
Curis (CRIS) United States $0.025B 0.00
Chemomab Therapeutics (CMMB) Israel $0.025B 0.00
Imunon (IMNN) United States $0.025B 0.00
Generation Bio (GBIO) United States $0.025B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.024B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.023B 0.00
CalciMedica (CALC) United States $0.023B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.023B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
Q32 Bio (QTTB) United States $0.022B 0.00
Ovid Therapeutics (OVID) United States $0.022B 0.00
X4 Pharmaceuticals (XFOR) United States $0.021B 0.00
Femasys (FEMY) United States $0.020B 0.00
Advanced Biomed (ADVB) United States $0.020B 0.00
HOOKIPA Pharma (HOOK) United States $0.019B 0.00
Elevation Oncology (ELEV) United States $0.018B 0.00
Cingulate (CING) United States $0.018B 0.00
Cognition Therapeutics (CGTX) United States $0.018B 0.00
Longeveron (LGVN) United States $0.018B 0.00
Lexaria Bioscience (LEXX) Canada $0.017B 0.00
SAB Biotherapeutics (SABS) United States $0.017B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.017B 0.00
GeoVax Labs (GOVX) United States $0.017B 0.00
Leap Therapeutics (LPTX) United States $0.016B 0.00
Gelteq (GELS) Australia $0.016B 0.00
Hoth Therapeutics (HOTH) United States $0.016B 0.00
Beyond Air (XAIR) United States $0.016B 0.00
Promis Neurosciences (PMN) Canada $0.016B 0.00
IBio (IBIO) United States $0.015B 0.00
Synlogic (SYBX) United States $0.014B 0.00
Rallybio (RLYB) United States $0.014B 0.00
NextCure (NXTC) United States $0.014B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.014B 0.00
MetaVia (MTVA) United States $0.014B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.013B 0.00
Biorestorative Therapies (BRTX) United States $0.013B 0.00
Athira Pharma (ATHA) United States $0.013B 0.00
Equillium (EQ) United States $0.013B 0.00
Abpro Holdings (ABP) United States $0.013B 0.00
BRIACELL THERAP (BCTX) Canada $0.012B 0.00
Bionano Genomics (BNGO) United States $0.012B 0.00
Allarity Therapeutics (ALLR) United States $0.012B 0.00
UNITY Biotechnology (UBX) United States $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.012B 0.00
Bolt Biotherapeutics (BOLT) United States $0.011B 0.00
BioCardia (BCDA) United States $0.011B 0.00
IN8bio (INAB) United States $0.011B 0.00
Cyclerion Therapeutics (CYCN) United States $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Moleculin Biotech (MBRX) United States $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
LakeShore Biopharma (LSB) China $0.009B 0.00
BioXcel Therapeutics (BTAI) United States $0.009B 0.00
Aytu BioPharma (AYTU) United States $0.009B 0.00
Sensei Biotherapeutics (SNSE) United States $0.009B 0.00
Eyenovia (EYEN) United States $0.009B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.009B 0.00
Portage Biotech (PRTG) $0.009B 0.00
HCW Biologics (HCWB) United States $0.009B 0.00
Intensity Therapeutics (INTS) United States $0.008B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
BioAffinity Technologies (BIAF) United States $0.008B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.008B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.008B 0.00
GENPREX (GNPX) United States $0.008B 0.00
Apollomics (APLM) United States $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
Arcadia Biosciences (RKDA) United States $0.007B 0.00
Avalon GloboCare (ALBT) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
180 Life Sciences (ATNF) United States $0.006B 0.00
Evogene (EVGN) Israel $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Jade Biosciences (JBIO) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
CNS Pharmaceuticals (CNSP) United States $0.006B 0.00
Mustang Bio (MBIO) United States $0.005B 0.00
Novogen (KZIA) Australia $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
Polyrizon (PLRZ) Israel $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
VivoSim Labs (VIVS) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Affimed (AFMD) Germany $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
Capstone Therapeutics (CAPS) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00